Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry
- PMID: 15700237
- DOI: 10.1002/rcm.1830
Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry
Abstract
Our experiments show that it is possible to detect different types of recombinant human erythropoietins (rhEPOs), EPO-alpha, EPO-beta and novel erythropoesis stimulating protein (NESP), based on exact molecular weight (MW) determination by matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) applying a high-resolution time-of-flight (TOF) mass analyser in the linear mode. Detection limits for the highly purified, intact glycoproteins were achievable in the low fmol range (25-50 fmol) using a sample preparation method applying a hydrophobic sample support (DropStop) as MALDI target surface. These results are very promising for the development of highly sensitive detection methods for a direct identification of rhEPO after enrichment from human body fluids. During our investigation we were able to differentiate EPO-alpha, EPO-beta and NESP based on distinct molecular substructures at the protein level by specific enzymatic reactions. MW determination of the intact molecules by high resolving one-dimensional sodium dodecyl sulfate /polyacrylamide gel electrophoresis (1D SDS-PAGE) and isoform separation by planar isoelectric focusing (IEF) was compared with MALDI-MS data. Migration differences between the rhEPOs were observed from gel electrophoresis, whereby MWs of 38 kDa in the case of EPO-alpha/beta and 49 kDa for NESP could be estimated. In contrast, an exact MW determination by MALDI-MS based on internal calibration revealed average MWs of 29.8 +/- 0.3 kDa for EPO-alpha/beta and 36.8 +/- 0.4 kDa for NESP. IEF separation of the intact rhEPOs revealed the presence of four to eight distinct isoforms in EPO-alpha and EPO-beta, while four isoforms, which appeared in the more acidic area of the gels, were detected by immunostaining in NESP. A direct detection of the different N- or O-glycoform pattern from rhEPOs using MALDI-MS was possible by de-sialylation of the glycan structures and after de-N-glycosylation of the intact molecules. Thereby, the main glycoforms of EPO-alpha, EPO-beta and NESP could be characterised based on their N-glycan composition. A microheterogeneity of the molecules based on the degree of sialylation of the O-glycan was observable directly from the de-N-glycosylated protein.
Similar articles
-
Capillary electrophoresis and matrix-assisted laser desorption/ionization-time of flight-mass spectrometry for analysis of the novel erythropoiesis-stimulating protein (NESP).Electrophoresis. 2005 Apr;26(7-8):1451-6. doi: 10.1002/elps.200410092. Electrophoresis. 2005. PMID: 15759304
-
Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration.J Mass Spectrom. 2002 Nov;37(11):1118-30. doi: 10.1002/jms.372. J Mass Spectrom. 2002. PMID: 12447888
-
A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor.Rapid Commun Mass Spectrom. 2010 Mar;24(6):761-7. doi: 10.1002/rcm.4440. Rapid Commun Mass Spectrom. 2010. PMID: 20169558
-
Applications and biomonitoring issues of recombinant erythropoietins for doping control.Ther Drug Monit. 2011 Feb;33(1):3-13. doi: 10.1097/FTD.0b013e31820032c4. Ther Drug Monit. 2011. PMID: 21099742 Review.
-
Methods in enzymology: O-glycosylation of proteins.Methods Enzymol. 2005;405:139-71. doi: 10.1016/S0076-6879(05)05007-X. Methods Enzymol. 2005. PMID: 16413314 Review.
Cited by
-
Proteoforms and their expanding role in laboratory medicine.Pract Lab Med. 2021 Nov 27;28:e00260. doi: 10.1016/j.plabm.2021.e00260. eCollection 2022 Jan. Pract Lab Med. 2021. PMID: 34950758 Free PMC article. Review.
-
MUW researcher of the month.Wien Klin Wochenschr. 2019 Sep;131(17-18):449-451. doi: 10.1007/s00508-019-01550-7. Wien Klin Wochenschr. 2019. PMID: 31531772 No abstract available.
-
An HPLC-MALDI MS method for N-glycan analyses using smaller size samples: application to monitor glycan modulation by medium conditions.Glycoconj J. 2009 Dec;26(9):1135-49. doi: 10.1007/s10719-009-9235-z. Glycoconj J. 2009. PMID: 19412663
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials